AVITA Medical, Inc. (RCEL)
NASDAQ: RCEL · Real-Time Price · USD
3.960
-0.160 (-3.88%)
Oct 22, 2025, 4:00 PM EDT - Market closed
AVITA Medical Market Cap
AVITA Medical has a market cap or net worth of $120.75 million as of October 23, 2025. Its market cap has decreased by -57.43% in one year.
Market Cap
120.75M
Enterprise Value
149.65M
1-Year Change
-57.43%
Ranking
Category
Stock Price
$3.96
Market Cap Chart
Since March 29, 2012, AVITA Medical's market cap has increased from $59.55M to $120.75M, an increase of 102.79%. That is a compound annual growth rate of 5.35%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 21, 2025 | 125.63M | -62.85% |
| Dec 31, 2024 | 338.19M | -4.00% |
| Dec 29, 2023 | 352.28M | 111.74% |
| Dec 30, 2022 | 166.38M | -44.28% |
| Dec 31, 2021 | 298.61M | -25.68% |
| Dec 31, 2020 | 401.79M | -58.30% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 726.23B |
| Johnson & Johnson | 466.54B |
| AbbVie | 409.95B |
| UnitedHealth Group | 330.10B |
| AstraZeneca | 261.56B |
| Novartis AG | 254.74B |
| Novo Nordisk | 249.65B |
| Abbott Laboratories | 225.41B |